Astrana Health Sees Q3 Sales $1.000B-$1.030B vs $1.021B Est

Benzinga Newsdesk www.benzinga.com Positive 83.5%

Neg 0% Neu 0% Pos 83.5%

Astrana Health (NASDAQ:ASTH) sees Q3 sales of $1.000 billion-$1.030 billion vs $1.021 billion analyst estimate.

Comments

No comments yet. Be the first!